Davis, SR, “The role of androgens and the menopause in the female sexual response”, in International Journal of Impotence Research (1998 Stockton Press) vol. 10, Suppl. 2, S82-S83.* |
Derogatis, LR and B Conklin-Powers, “Psychological assessment measures of female sexual functioning in clinical trials”, in International Journal of Impotence Research (1998 Stockton Press) vol. 10, Suppl. 2, S111-116.* |
Fourcroy, Jean, “Discussion: Female sexual function—mechanisms and models”, in International Journal of Impotence Research (1998 Stockton Press) vol. 10, Suppl. 2, S98-S101.* |
Fourcroy, JL, “Issues and priorities in the development of drug treatments for female sexual dysfunction”, in International Journal of Impotence Research (1998 Stockton Press) vol. 10, Suppl. 2, S121-S123.* |
Goldstein, I, and Berman, JR, “Vasculogenic female sexual dysfunction: vaginal engorgement and clitoral erectile insufficiency syndromes”, in International Journal of Impotence Research (1998 Stockton Press) vol. 10, Suppl. 2, S84-S90.* |
Harvard Scientific Corp., Harvard Scientific Acquires Rights to Oral Treatment for Both Male & Female Sexual Dysfunction pp. 1-3, (Jun. 12, 1998). (Downloaded from the Internet at http://biz.yahoo.com/.) |
Heiman, JR, “Psychophysiological models of female sexual response”, in International Journal of Impotence Research (1998 Stockton Press) vol. 10, Suppl. 2, S94-S97.* |
Laan, E and Everaerd, W, “Physiological measures of vaginal vasocongestion”, in International Journal of Impotence Research (1998 Stockton Press) vol. 10, Suppl. 2, S107-S110.* |
Leiblum, SR, “Definition and classification of female sexual discorders”, in International Journal of Impotence Research (1998 Stockton Press) vol. 10, Suppl. 2, S104-S106.* |
Phillips, NA, “The clinical evaluation of dyspareunia”, in International Journal of Impotence Research (1998 Stockton Press) vol. 10, Suppl. 2, S117-S120.* |
Sarrel, PM, “Ovarian hormones and vaginal blood flow: using laser Doppler velocimetry to measure effects in a clinical trial of post-menopausal women”, in International Journal of Impotence Research (1998 Stockton Press) vol. 10, Suppl. 2, S91-S93.* |
*This information was first presented at the Cape Cod Conference of May 20-31, 1997. The references were first published in the United Kingdom on Feb. 6, 1998 and distributed for overseas publication on May 6, 1998. |
PubMed/NCBI abstract, accessed Aug. 27, 2001, for: Davis, S.R., “The clinical use of androgens in female sexual disorders,” J. Sex. Marital Ther. 24:153-163, Brunner-Routledge (Jul.-Sep. 1998). |
PubMed/NCBI abstract, accessed Aug. 27, 2001, for: Kennedy, R.G. et al., “Sexual interest in postmenopausal women is related to 5alpha-reductase activity,” Hum. Reprod. 12:209-213, Oxford University Press, HighWire Press and The European Society of Human Reproduction and Embryology (Feb. 1997). |
PubMed/NCBI abstract, accessed Sep. 24, 2001, for: Kirchengast, S. et al., “Decreased sexual interest and its relationship to body build in postmenopausal women,” Maturitas 23:63-71, European Menopause and Andropause Society (EMAS) and Elsevier Science Ltd. (Feb. 1996). |
Lloyd, R.V. and Fields, K.L., “Regulation of dopamine receptors in the MtT/W15 transplantable pituitary tumor by estrogen,” Mol. Cell. Endocrinol. 44:133-139, Elsevier Scientific Publishers Ireland, Ltd. (1986). |
PubMed/NCBI abstract, accessed Aug. 27, 2001, for: Mathews, A., “Progress in the treatment of female sexual dysfunction,” J. Psychosom. Res. 27:165-173, Elsevier Science Ltd. (1983). |
PubMed/NCBI abstract, accessed Aug. 27, 2001, for: Tutten, A. et al., “Discrepancies between genital responses and subjective sexual function during testosterone substitution in women with hypothalamic amenorrhea,” Psychosom. Med. 58:234-241, American Psychosomatic Society (May-Jun. 1996). |
Ferrari, F. et al., Influence of Apomorphine on Rat Female Sexual Behaviour and its Relation with Induction of Stereotypy, Rivista di Farmacologia e Terapia VIII, pp. 355-363 (1977). |
Melis, Maria Rosaria et al., Dopamine and Sexual Behaviour, Neuroscience and Biobehavioral Reviews, vol. 19, No. 1, pp. 19-38 (1995). |
Segraves, R. T. et al., Pharmacotherapy for Sexual Disorders: Advantages and Pitfalls, Sexual and Marital Therapy, vol. 13, No. 3, pp. 295-309 (1998). |
Tagliamonte et al., Pharm. Biochem. and Behavior vol. 2, pp. 257-260 (1974). |
Laduron et al., Biochem. Pharmacology, vol. 28, pp. 2161-2165 (1979). |
Baldessarini et al., in Gessa et al., Apomorphine & Other Dopaminomimetics, vol. 1, Basic Pharmacology, pp. 219-288 (1981). |
Lal et al., J. Neural Transmission, vol. 54, pp. 75-84 (1982). |
Reynolds, James E. F., ed., Martindale, 28th Edition, pp. 891-892 (1982). |
Gower et al., European J. of Pharmacology, vol. 122, pp. 239-244 (1986). |
Melis et al., Brain Research, vol. 415, 98-104 (1987). |
Segraves et al., Archives of Sexual Behavior, vol. 16, No. 2, pp. 125-137 (1987). |
Danjou et al., Br. J. Clin. Pharmac., vol. 26, pp. 733-739 (1988). |
Lal S., Prog. Neuro-Psychopharm. & Biol. Psych., vol. 12, pp. 117-164 (1988). |
Pehek et al., Pharm. Biochem. and Behavior 31:201-208 (1988). |
Danjou et al., J. Pharmacol. Methods, vol. 21, pp. 61-69 (1989). |
Gancher et al., Am. Neurol., vol. 26, pp. 232-238 (1989). |
Segraves R. T., Arch. Gen. Psych., vol. 46, pp. 275-284 (1989). |
Durif et al., Eur. J. Clin. Pharmacology, vol. 41, pp. 493-494 (1991). |
Essink et al., J. Chromatography, vol., 570, pp. 419-424 (1991). |
Gancher et al., Movement Disorders, vol. 6, No. 3, pp. 212-216 (1991). |
Heaton et al., J. Urology, vol. 145, pp. 192-194 (1991). |
Heaton et al., J. Urology, vol. 145 pp. 1099-1102 (1991). |
Lal et al., J. Psych. Neurosci., vol. 16, No. 5, pp. 262-266 (1991). |
Montastruc et al., Clin. Neuropharmacology, vol. 14, No. 5, pp. 432-437 (1991). |
Panegyres et al., Med. J. Australia, vol. 155, pp. 371-374 (1991). |
Segraves et al., J. Urology, vol. 145, pp. 1174-1175 (1991). |
Durif et al., Clinical Neuropharmacology, vol. 16, No. 2, pp. 157-166 (1993). |
Heaton et al., J. Urology, vol. 151, pp. 797-800 (1994). |
Bancroft, J., editor, The Pharmacology of Sexual Function and Dysfunction, pp. 225-229 (1995). |
Goodman and Gilman, eds., The Pharmacological Basis of Therapeutics, 9th Edition, pp. 4-9 (1996). |
Hamburger-Bar, Rachel, et al, “Apomorphine: Facilitation of Sexual Behaviour in Female Rats”, European Journal of Pharmacology, vol. 32, pp. 357-360 (1975). |
Hruska, Robert E., and E.K. Silbergeld, “Estrogen Treatment Enhances Dopamine Receptor Sensitivity in the Rat Striatum”, European Journal of Pharmacology, vol. 61, pp. 397-400 (1980). |
Bancroft, M.D., “Hormones and Human Sexual Behavior”, Journal of Sex & Marital Therapy, vol. 10, No. 1, pp. 3-19 (1984). |
Fernandez-Guasti, A., et al., “Separation of Dopaminergic and Serotonergic Inhabitory Mechanisms in the Mediation of Estrogen-Induced Lordosis Behaviour in the Rat”, Pharmacol Biochem Behav 27(1), pp. 93-98, (1987). |
Kazandjian, A. et al., “Apomorphine-induced Behaviour During the Oestrous Cycle of the Rat”, Neuropharmacology, vol. 26, No. 8, pp. 1037-1045 (1987). |
Kaplan, Helen Singer and Trude Owett, “The Female Androgen Deficiency Syndrome”, Journal of Sex & Marital Therapy, vol. 19, No. 1, Spring, pp. 3-21 (1993). |
Meston, Cindy M., and Boris B. Gorzalka, “Differential Effects of Sympathetic Activation on Sexual Arousal in Sexually Dysfunctional and Functional Women”, Journal of Abnormal Psychology, vol. 105, No. 4, pp. 582-591(1996). |
Whipple, Beverly, et al., “Sexual Response to Self-stimulation in Women With Complete Spinal Cord Injury”, The Journal of Sex Research, vol. 33, No. 3, pp. 231-240 (1996). |
Komisaruk, Barry R., et al., “‘Complete’ Spinal Cord Injury Does Not Block perceptual responses to Genital Self-stimulation in Women”, Archives of Neurology, vol. 54, pp. 1513-1520 (1997). |
Meston, Cindy M., PhD, et al., “Inhibition of Subjective and Physiological Sexual Arousal in Women by Clonidine”, Psychosomatic Medicine, vol. 59, pp. 399-407 (1997). |
Berman, Jennifer R., et al., “Effect of Estrogen Withdrawal on Nitric Oxide Synthase Expression and Apoptosis in the Rat Vagina”, Urology, vol. 51(4), pp. 650-656 (1998). |
Meston, Cindy M., PhD, and Julia R. Heiman, PhD, “Ephedrine-Activated Physiological Sexual Arousal in Women”, Arch Gen Psychiatry, vol. 55, pp. 652-656 (Jul. 1998). |
Azadzoi, Kazem, M.D., “Arterial Insufficiency and Femal Sexual Dysfunction”.** |
Fleming, Sandra, “Arteriogram Studies in Women with Peripheral Vascular Disease”.** |
Leiblum, Sandra, Ph.D., “Classification of Femal Sexual Dysfunctions: Issues and Controversies”.** |
Redmond, Geoffrey, M.D., “Testosterone and Female Sexual Dysfunction”.** |
Weiss, Robert M., M.D., “Estrogen Deficiency and Female Sexual Dysfunction”.** |
Azadzoi, Kazem M., et al., “Mechanism of clitoral cavernosal and vaginal tissue contractility in the rabbit”, 94th Annual Meeting, American Urological Association,(May 1999). |
**This information was published as material for a course offered by Boston University School of Medicine and Department of Urology on Oct. 23-25, 1998. The course was entitled “New Perspectives In the Management of Female Sexual Dysfunction”. |
Ferrari, F. et al., Influence of Apomorphine on Rat Female Sexual Behaviour and its Relation with Induction of Stereotypy, Rivista di Farmacologia e Terapia VIII, pp. 355-363 (1977). |
Melis, Maria Rosaria et al., Dopamine and Sexual Behavior, Neuroscience and Biobehavioral Reviews, vol. 19, No. 1, pp. 19-38 (1995). |
Tagliamonte et al., “Possible Stimulatory Role of Brain Dopamine in the Copulatory Behavior of Male Rats”, Pharmacology Biochemistry and Behavior, vol. 2, pp. 257-260(1974). |
Hamburger-Bar, Rachel et al, “Apomorphine: Facilitation of Sexual Behaviour in Female Rats”, European Journal of Pharmacology, vol. 32, pp. 357-360(1975). |
Database CaPlus, DN 92:70106. Soulairac, A. Sex. Endocrinol.: Horm. Relat. Physiopathol. Pregnancy, Horm. Invest., Hypothal.-Hyophyseal Relat., [Proc. Symp. Fond. Rech. Endocrinol. Sex. Reprod. Hum.], 4th (1978), Meeting Date 1976, 153-74. Edi. |
Foreman, Mark M., et al., “Role of Hypothalamic Dopaminergic Receptors in the Control of Lordosis Behavior in the Female Rat”, Physiology & Behavior, vol. 23, pp. 283-289 (1979). |
Laduron et al., “Domperidone, A Specific In Vitro Dopamine Antagonist, Devoid of In Vivo Central Dopaminergic Activity”, Biochemical Pharmacology, vol. 28, pp. 2161-2165 (1979). |
Hruska, Robert E., and E.K. Silbergeld, “Estrogen Treatment Enhances Dopamine Receptor Sensitivity in the Rat Striatum”, European Journal of Pharmacology, vol. 61, pp. 397-400 (1980). |
Baldessarini, R.J. et al., “Preclinical Studies of the Pharmacology of Aporphines”, G.L. Gessa et al., eds., Apomorphine & Other Dopaminomimetics, vol. 1: Basic Pharmacology, Raven Press, N.Y. pp. 219-228 (1981). |
Lal et al., “Effect of Domperidone on Apomorphine-Induced Growth Hormone Secretion in Normal Men”, Journal of Neural Transmission, vol. 54, pp. 75-84(1982). |
Reynolds, James E. F., Ed., Martindale, “The Extra Pharmacopoeia 28th Edition”, The Pharmaceutical Press, London. pp. 891-892(1982). |
Bancroft, M.D., “Hormones and Human Sexual Behavior”, Journal of Sex & Marital Therapy, vol. 10, No. 1, pp. 3-19(1984). |
Gower et al., “Antagonism of Drug-Induced Yawning and Penile Erections in Rats”, European Journal of Pharmacology, vol. 122, pp. 239-244(1986). |
Fernandez-Guasti, A., et al., “Separation of Dopaminergic and Serotonergic Inhabitory Mechanisms in the Mediation of Estrogen-Induced Lordosis Behaviour in the Rat”, Pharmacol Biochem Behav 27(1), pp. 93-98, (1987). |
Kazandjian, A. et al., “Apomorphine-induced Behaviour During the Oestrous Cycle of the Rat”, Neuropharmacology, vol. 26, No. 8, pp. 1037-1045(1987). |
Melis, Maria Rosaria, et al., “Apomorphine-induced penile erection and yawning: siste of action in brain”, Brain Research, vol. 415, pp. 98-104(1987). |
Segraves, K.A. et al., “Use of Sexual History to Differentiate Organic from Psychogenic Impotence”, Archives of Sexual Behavior, vol. 16(2), pp. 125-137(1987). |
Danjou et al., “Assessment of erectogenic properties of apomorphine and yohimbine in man”, Br. J. Clin. Pharmac., vol. 26, pp. 733-739(1988). |
Lal, Samarthji, “Apomorphine in the Evaluation of Dopaminergic Function in Man”, Prog. Neuro-Psychopharmacol. & Biol. Psychiat. vol. 12, pp. 117-164(1988). |
Pehek et al., “Apomorphine and Haloperidon, but not Domperidone, affect Penile Reflexes in Rats”, Pharmacology Biochemistry & Behavior, vol. 31, pp. 201-208(1988). |
Danjou, P., et al., “Assessment of Erectogenic Drugs by numeric Plethysmography”, Journal of Pharmacological Methods, vol. 21, pp. 61-69(1989). |
Gancher et al., “Peripheral Pharmacokinetics of Apomorphine in Humans”, Am. Neurol Assoc., vol. 26, pp. 232-238(1989). |
Segraves, R. Taylor, “Effects of Psychotropic Drugs on Human Erection and Ejaculation”, Arch. Gen. Psychiatry, vol. 46, pp. 275-284 (1989). |
Durif, F., et al., “Relation between plasma concentration and clinical efficacy after sublingual single dose apomorphine in Parkinson's disease”, European Journal of Clinical Pharmacology., vol. 41, pp. 493-494 (1991). |
Essink, A.W.G., et al., “Selective and quantitative isolation and determination of apomorphine in human plasma”, Journal of Chromatography, vol. 570, pp. 419-424(1991). |
Gancher, Stephen T., et al., “Absorption of Apomorphine by Various Routes in Parkinsonism”, Movement Disorders, vol. 6(3), pp. 212-216 (1991). |
Heaton, J.P.W., and S. Varrin, “The Impact of Alcohol Ingestion on Erections in Rats as Measured by a Novel Bio-assay”, The Journal of Urology, vol. 145, pp. 192-194(1991). |
Heaton, Jeremy P.W., et al., “The Characterization of a Bio-assay of Erectile Function in a Rat Model”, The Journal of Urology, vol. 145, pp. 1099-1102(1991). |
Lal, S., et al., “Effect of Bromocriptine in Patients With Apomorphine-Responsive Erectile Impotence: An Open Study”, J. Psychiatr. Neurosci., vol. 16(5), pp. 262-266(1991). |
Levin, R.J., “VIP, Vagina, clitoral and Periurethral Glans—an Update of Human Female Genital Arousal”, Exp. Clin. Endocrinol., vol. 98, No. 2, pp. 61-69(1991). |
Montastruc, J.L., et al., “Sublingual Apomorphine in Parkinson's Disease: A clinical and Pharmacokietic Study”, Clinical Neuropharmacology, vol. 14(5), pp. 432-437(1991). |
Panegyres, Peter K., et al., “Sublingual apomorphine solution in Parkinson's disease”, The Medical Journal of Australia, vol. 155, pp. 371-374(1991). |
Segraves, R.T., et al., “Effect of Apomorphine on Penile Tumescence in Men with Psychogenic Impotence”, The Journal of Urology, vol. 145, pp. 1174-1175(1991). |
Database MEDLINE, DN 92217484. Bertschy et al. Encephale, 17(6) 515-7(Nov. 1991). |
Durif, F., et al., “Relation Between Clinical Efficacy and Pharmacokinetic Parameters After Sublingual Apomorphine in Parkinson's Disease”, Clinical Neuropharmacology, vol. 16(2), pp. 157-166(1993). |
Kaplan, Helen Singer and Trude Owett, “The Female Androgen Deficiency Syndrome”, Journal of Sex & Marital Therapy, vol. 19, No. 1, Spring, pp. 3-21(1993). |
Heaton, Jeremy P.W. and Shawn J. Varrin, Effects of Castration and Exogenous Testosterone Supplementation in an Animal Model of Penile Erection, The Journal of Urology, vol. 151, pp. 797-800(1994). |
Bancroft, J., editor, The Pharmacology of Sexual Function and Dysfunction, Excerpta Medica, Amsterdam, pp. 225-229 (1995). |
Goodman and Gilman, eds., The Pharmacological Basis of Therapeutics, 9th Edition, McGraw-Hill, New York, N.Y., pp. 4-9(1996). |
Meston, Cindy M., and Boris B. Gorzalka, “Differential Effects of Sympathetic Activation on Sexual Arousal in Sexually Dysfunctional and Functional Women”, Journal of Abnormal Psychology, vol. 105, No. 4, pp. 582-591(1996). |
Whipple, Beverly, et al., “Sexual Response to Self-stimulation in Women With complete Spinal Cord Injury”, The Journal of Sex Research, vol. 33., No. 3, pp. 231-240(1996). |
Komisaruk, Barry R., et al., “‘Complete’ Spinal Cord Injury Does Not Block perceptual responses to Genital Self-stimulation in Women”, Archives of Neurology, vol. 54, pp. 1513-1520(1997). |
Meston, Cindy M., PhD, et al., “Inhibition of Subjective and Physiological Sexual Arousal in Women by Clonidine”, Psychosomatic Medicine, vol. 59, pp. 399-407(1997). |
Berman, Jennifer R., et al., “Effect of Estrogen Withdrawal on Nitric Oxide Synthase Expression and Apoptosis in the Rat Vagina”, Urology, vol. 51(4), pp. 650-656(1998). |
Davis, SR, “The role of androgens and the menopause in the female sexual response”, in International Journal of Impotence Research (1998 Stockton Press) vol. 10, Suppl. 2, S82-S83.* |
Derogatis, LR and B Conklin-Powers, “Psychological assessment measures of female sexual functioning in clinical trials”, in International Journal of Impotence Research (1998 Stockton Press) vol. 10, Suppl. 2, S111-116.* |
Fourcroy, Jean, “Discussion: Female sexual function—mechanisms and models”, in International Journal of Impotence Research (1998 Stockton Press) vol. 10, Suppl. 2, S98-S101.* |
Fourcroy, JL, “Issues and priorities in the development of drug treatments for female sexual dysfunction”, in International Journal of Impotence Research (1998 Stockton Press) vol. 10, Suppl. 2, S121-S123.* |
Goldstein, I, and Berman, JR, “Vasculogenic female sexual dysfunction: vaginal engorgement and clitoral erectile insufficiency syndromes” in International Journal of Impotence Research (1998 Stockton Press) vol. 10, Suppl. 2, S84-S90.* |
Harvard Scientific Corp., Harvard Scientific Acquires Rights to Oral Treatment for Both Male & Female Sexual Dysfunction, pp. 1-3, (Jun. 12, 1998). (Downloaded from the Internet at http://biz.yahoo.com/.). |
Heiman, JR, “Psychophysiological models of female sexual response”, in International Journal of Impotence Research (1998 Stockton Press) vol. 10, Suppl. 2, S94-S97.* |
Laan, E and Everaerd, W, “Physiological measures of vaginal vasocongestion”, in International Journal of Impotence Research (1998 Stockton Press) vol. 10, Suppl. 2, S107-S110.* |
Leiblum, SR, “Definition and classification of female sexual disorders”, in International Journal of Impotence Research (1998 Stockton Press) vol. 10, Suppl. 2, S104-S106.* |
Phillips, NA, “The clinical evaluation of dyspareunia”, in International Journal of Impotence Research (1998 Stockton Press) vol. 10, Suppl. 2, S117-S120.* |
Sarrel, PM, “Ovarian hormones and vaginal blood flow: using laser Doppler velocimetry to measure effects in a clinical trial of post-menopausal women”, in International Journal of Impotence Research (1998 Stockton Press) vol. 10, Suppl. 2, S91-S93.* |
Meston, Cindy M., PhD, and Julia R. Heiman, PhD, “Ephedrine-Activated Physiological Sexual Arousal in Women”, Arch Gen Psychiatry, vol. 55, pp. 652-656 (Jul. 1998). |
Azadzoi, Kazem, M.D., “Arterial Insufficiency and Female Sexual Dysfunction”.** |
Fleming, Sandra, “Arteriogram Studies in Women with Peripheral Vascular Disease”.** |
Leiblum, Sandra, Ph.D., “Classification of Female Sexual Dysfunctions: Issues and Controversies”.** |
Redmond, Geoffrey, M.D., “Testosterone and Female Sexual Dysfunction”.** |
Weiss, Robert M., M.D., “Estrogen Deficiency and Female Sexual Dysfunction”.** |
Azadzoi, Kazem M., et al., “Mechanism of clitoral cavernosal and vaginal tissue contractility in the rabbit”, 94th Annual Meeting, American Urological Association,(May 1999). |
*This information was first presented at the Cape Cod Conference May 20-31, 1997. The references were first published in the United Kingdom on Feb. 6, 1998 and distributed for overseas publication on May 6, 1998. |
** This information was published as material for a course offered by Boston University School of Medicine and Department of Urology on Oct. 23-25, 1998. The course was entitled “New Perspectives In the Management of Female Sexual Dysfunction”. |